TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PWY-0	putrescine degradation III	0.00139783424775408	-6.57283120603805	9	4	0.0701754385964912	57	907	221,217,224,6303	ALDH3B1,ALDH2,ALDH3A2,SAT1
META_PWY-4041	gamma-glutamyl cycle	0.0038844308797735	-5.55077879758628	2	2	0.0350877192982456	57	907	2730,2729	GCLM,GCLC
META_PWY-5340	sulfate activation for sulfonation	0.0038844308797735	-5.55077879758628	2	2	0.0350877192982456	57	907	9060,9061	PAPSS2,PAPSS1
HUMAN_PWY-5340	sulfate activation for sulfonation	0.0038844308797735	-5.55077879758628	2	2	0.0350877192982456	57	907	9060,9061	PAPSS2,PAPSS1
META_PWY-0	putrescine degradation III	0.0111811518693742	-4.49352578710134	3	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.0113788248911699	-4.47600111649711	15	4	0.0701754385964912	57	907	337876,29940,64132,79586	CHSY3,DSE,XYLT2,CHPF
META_PWY-6571	dermatan sulfate biosynthesis	0.0113788248911699	-4.47600111649711	15	4	0.0701754385964912	57	907	337876,29940,64132,79586	CHSY3,DSE,XYLT2,CHPF
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.0214603268478386	-3.84154931133459	4	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
META_PWY66-21	ethanol degradation II	0.0214603268478386	-3.84154931133459	4	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
META_PWY66-162	ethanol degradation IV	0.0214603268478386	-3.84154931133459	4	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.0214603268478386	-3.84154931133459	4	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
META_PWY66-161	oxidative ethanol degradation III	0.0214603268478386	-3.84154931133459	4	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	1633,978	DCK,CDA
META_CITRULBIO-PWY	L-citrulline biosynthesis	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	5625,4942	PRODH,OAT
META_PWY-6566	chondroitin biosynthesis	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	337876,79586	CHSY3,CHPF
HUMAN_PWY-6566	chondroitin and dermatan biosynthesis	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	337876,79586	CHSY3,CHPF
META_PWY-6313	serotonin degradation	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY66-21	ethanol degradation II	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY66-162	ethanol degradation IV	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	1633,978	DCK,CDA
HUMAN_PWY-5030	histidine degradation	0.0343311136793824	-3.37170323162559	5	2	0.0350877192982456	57	907	144193,3034	AMDHD1,HAL
META_PWY-6342	noradrenaline and adrenaline degradation	0.049438592124957	-3.00702394267512	6	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY66-161	oxidative ethanol degradation III	0.049438592124957	-3.00702394267512	6	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
META_PWY-6564	heparan sulfate biosynthesis	0.0506319167993385	-2.98317313475313	23	4	0.0701754385964912	57	907	9394,9953,64132,26035	HS6ST1,HS3ST3B1,XYLT2,GLCE
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.0624324632867819	-2.77366989390678	15	3	0.0526315789473684	57	907	129607,1633,978	CMPK2,DCK,CDA
META_PWY-5329	L-cysteine degradation III	0.0628445424477424	-2.76709118227879	1	1	0.0175438596491228	57	907	2805	GOT1
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	0.0628445424477424	-2.76709118227879	1	1	0.0175438596491228	57	907	2805	GOT1
META_PWY66-389	phytol degradation	0.0628445424477424	-2.76709118227879	1	1	0.0175438596491228	57	907	224	ALDH3A2
META_HISHP-PWY	L-histidine degradation VI	0.0628445424477424	-2.76709118227879	1	1	0.0175438596491228	57	907	3034	HAL
HUMAN_PWY-5329	L-cysteine degradation II	0.0628445424477424	-2.76709118227879	1	1	0.0175438596491228	57	907	2805	GOT1
HUMAN_PWY66-389	phytol degradation	0.0628445424477424	-2.76709118227879	1	1	0.0175438596491228	57	907	224	ALDH3A2
HUMAN_PWY-2161B	glutamate removal from folates	0.0628445424477424	-2.76709118227879	1	1	0.0175438596491228	57	907	8836	GGH
HUMAN_PWY-6313	serotonin degradation	0.0664609141204969	-2.71114126170404	7	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.0743131312189573	-2.59946761045172	26	4	0.0701754385964912	57	907	9394,9953,64132,26035	HS6ST1,HS3ST3B1,XYLT2,GLCE
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.0851066612692059	-2.46384997068234	8	2	0.0350877192982456	57	907	11320,11282	MGAT4A,MGAT4B
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.0853837637346426	-2.460599316466	17	3	0.0526315789473684	57	907	9394,9953,26035	HS6ST1,HS3ST3B1,GLCE
META_PWY-6569	chondroitin sulfate biosynthesis	0.0980339639374903	-2.32244128956263	18	3	0.0526315789473684	57	907	337876,64132,79586	CHSY3,XYLT2,CHPF
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.111400985102251	-2.19461910859941	19	3	0.0526315789473684	57	907	337876,64132,79586	CHSY3,XYLT2,CHPF
HUMAN_PWY0-662	PRPP biosynthesis	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	5634	PRPS2
META_PWY-6117	spermine and spermidine degradation I	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	6303	SAT1
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	978	CDA
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	2805	GOT1
META_PWY-5030	L-histidine degradation III	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	3034	HAL
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	10157	AASS
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	2805	GOT1
META_PWY0-662	PRPP biosynthesis I	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	5634	PRPS2
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	10157	AASS
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	224	ALDH3A2
META_PWY66-388	fatty acid alpha-oxidation III	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	224	ALDH3A2
META_PROUT-PWY	L-proline degradation	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	5625	PRODH
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	2805	GOT1
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.121804654013556	-2.10533671414442	2	1	0.0175438596491228	57	907	2673	GFPT1
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.125432107080112	-2.07599064623381	20	3	0.0526315789473684	57	907	9394,9953,26035	HS6ST1,HS3ST3B1,GLCE
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	0.126240388792516	-2.06956734210069	10	2	0.0350877192982456	57	907	217,224	ALDH2,ALDH3A2
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.126240388792516	-2.06956734210069	10	2	0.0350877192982456	57	907	1633,978	DCK,CDA
META_PWY-5004	superpathway of L-citrulline metabolism	0.148276522143759	-1.90867635562965	11	2	0.0350877192982456	57	907	5625,4942	PRODH,OAT
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	6697	SPR
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	978	CDA
META_ARGININE-SYN4-PWY	L-ornithine de novo  biosynthesis	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	4942	OAT
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	978	CDA
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	224	ALDH3A2
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	2805	GOT1
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	2805	GOT1
META_PWY6666-2	dopamine degradation	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	224	ALDH3A2
META_PWY-6875	retinoate biosynthesis II	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	7498	XDH
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	4942	OAT
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	6697	SPR
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	6697	SPR
META_PWY-2301	myo-inositol biosynthesis	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	54928	IMPAD1
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	978	CDA
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	4942	OAT
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.177116405088276	-1.73094810670319	3	1	0.0175438596491228	57	907	32	ACACB
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.194323239255516	-1.63823232473018	13	2	0.0350877192982456	57	907	337876,79586	CHSY3,CHPF
META_PWY-6352	3-phosphoinositide biosynthesis	0.203635684585301	-1.59142274156274	25	3	0.0526315789473684	57	907	5287,5293,5295	PIK3C2B,PIK3CD,PIK3R1
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.203635684585301	-1.59142274156274	25	3	0.0526315789473684	57	907	2591,79695,2650	GALNT3,GALNT12,GCNT1
HUMAN_PWY6666-2	dopamine degradation	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	224	ALDH3A2
HUMAN_PWY-6117	spermine and spermidine degradation I	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	6303	SAT1
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	29940	DSE
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	2805	GOT1
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	978	CDA
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	63826	SRR
META_PWY-6608	guanosine nucleotides degradation III	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	7498	XDH
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	2805	GOT1
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	224	ALDH3A2
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	8309	ACOX2
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	29940	DSE
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	2950	GSTP1
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	224	ALDH3A2
META_PWY66-387	fatty acid alpha-oxidation II	0.229001764502161	-1.47402557020797	4	1	0.0175438596491228	57	907	224	ALDH3A2
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.23765760638181	-1.43692426977827	27	3	0.0526315789473684	57	907	5287,5293,5295	PIK3C2B,PIK3CD,PIK3R1
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	10555	AGPAT2
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	2650	GCNT1
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	978	CDA
HUMAN_PWY66-375	leukotriene biosynthesis	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	4048	LTA4H
META_PWY66-375	leukotriene biosynthesis	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	4048	LTA4H
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	221	ALDH3B1
META_TYRFUMCAT-PWY	L-tyrosine degradation I	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	2184	FAH
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	7498	XDH
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	2184	FAH
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	250	ALPP
HUMAN_PWY66-241	bupropion degradation	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	113612	CYP2U1
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	2673	GFPT1
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	978	CDA
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	0.27766942720834	-1.28132398360603	5	1	0.0175438596491228	57	907	32	ACACB
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.323315594225598	-1.12912636087766	6	1	0.0175438596491228	57	907	64132	XYLT2
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.323315594225598	-1.12912636087766	6	1	0.0175438596491228	57	907	7498	XDH
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	0.323315594225598	-1.12912636087766	6	1	0.0175438596491228	57	907	978	CDA
META_PWY-5327	superpathway of L-lysine degradation	0.323315594225598	-1.12912636087766	6	1	0.0175438596491228	57	907	10157	AASS
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.323315594225598	-1.12912636087766	6	1	0.0175438596491228	57	907	64132	XYLT2
HUMAN_PWY-4061	glutathione-mediated detoxification	0.337939827215279	-1.08488742533793	19	2	0.0350877192982456	57	907	8836,2950	GGH,GSTP1
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.337939827215279	-1.08488742533793	19	2	0.0350877192982456	57	907	3706,54928	ITPKA,IMPAD1
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.361551796119364	-1.01734996654233	20	2	0.0350877192982456	57	907	3706,54928	ITPKA,IMPAD1
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.361768014837101	-1.01675211557544	34	3	0.0526315789473684	57	907	217,113612,224	ALDH2,CYP2U1,ALDH3A2
META_LEU-DEG2-PWY	L-leucine degradation I	0.366124707576887	-1.00478127253203	7	1	0.0175438596491228	57	907	64087	MCCC2
META_PWY-6872	retinoate biosynthesis I	0.366124707576887	-1.00478127253203	7	1	0.0175438596491228	57	907	220	ALDH1A3
HUMAN_PWY66-221	nicotine degradation III	0.366124707576887	-1.00478127253203	7	1	0.0175438596491228	57	907	113612	CYP2U1
META_PWY-7224	purine deoxyribonucleosides salvage	0.366124707576887	-1.00478127253203	7	1	0.0175438596491228	57	907	1633	DCK
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.401461526356104	-0.912643574953671	66	5	0.087719298245614	57	907	5287,5293,3706,5295,5336	PIK3C2B,PIK3CD,ITPKA,PIK3R1,PLCG2
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	0.406270142764274	-0.900736964378364	8	1	0.0175438596491228	57	907	113612	CYP2U1
HUMAN_PWY-6872	retinoate biosynthesis I	0.406270142764274	-0.900736964378364	8	1	0.0175438596491228	57	907	220	ALDH1A3
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.443914861188283	-0.812122489017521	9	1	0.0175438596491228	57	907	79868	ALG13
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.443914861188283	-0.812122489017521	9	1	0.0175438596491228	57	907	5336	PLCG2
HUMAN_PWY-7205	CMP phosphorylation	0.443914861188283	-0.812122489017521	9	1	0.0175438596491228	57	907	129607	CMPK2
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.443914861188283	-0.812122489017521	9	1	0.0175438596491228	57	907	7498	XDH
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.474139618344882	-0.746253447189203	25	2	0.0350877192982456	57	907	10555,8613	AGPAT2,PLPP3
HUMAN_PWY-6398	melatonin degradation I	0.47921202478861	-0.735612139030354	10	1	0.0175438596491228	57	907	113612	CYP2U1
HUMAN_PWY66-201	nicotine degradation IV	0.47921202478861	-0.735612139030354	10	1	0.0175438596491228	57	907	113612	CYP2U1
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.47921202478861	-0.735612139030354	10	1	0.0175438596491228	57	907	129607	CMPK2
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.512305575053249	-0.668834005696722	11	1	0.0175438596491228	57	907	54928	IMPAD1
HUMAN_LEU-DEG2-PWY	leucine degradation	0.512305575053249	-0.668834005696722	11	1	0.0175438596491228	57	907	64087	MCCC2
HUMAN_PWY-6402	superpathway of melatonin degradation	0.512305575053249	-0.668834005696722	11	1	0.0175438596491228	57	907	113612	CYP2U1
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.512305575053249	-0.668834005696722	11	1	0.0175438596491228	57	907	1633	DCK
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.512305575053249	-0.668834005696722	11	1	0.0175438596491228	57	907	129607	CMPK2
HUMAN_PWY-7511	protein ubiquitylation	0.535949903296165	-0.62371458627906	28	2	0.0350877192982456	57	907	92912,51465	UBE2Q2,UBE2J1
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.543330778427359	-0.610036976141429	12	1	0.0175438596491228	57	907	8309	ACOX2
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.543330778427359	-0.610036976141429	12	1	0.0175438596491228	57	907	8309	ACOX2
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.572414740025558	-0.557891480363828	13	1	0.0175438596491228	57	907	129607	CMPK2
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.572414740025558	-0.557891480363828	13	1	0.0175438596491228	57	907	5336	PLCG2
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.572414740025558	-0.557891480363828	13	1	0.0175438596491228	57	907	8309	ACOX2
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.572414740025558	-0.557891480363828	13	1	0.0175438596491228	57	907	54928	IMPAD1
HUMAN_PWY-5328	superpathway of methionine degradation	0.599676887474281	-0.511364289696634	14	1	0.0175438596491228	57	907	2805	GOT1
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.599676887474281	-0.511364289696634	14	1	0.0175438596491228	57	907	2805	GOT1
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.625229426573658	-0.469636614086187	15	1	0.0175438596491228	57	907	2026	ENO2
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.625229426573658	-0.469636614086187	15	1	0.0175438596491228	57	907	3706	ITPKA
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.625229426573658	-0.469636614086187	15	1	0.0175438596491228	57	907	3706	ITPKA
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.625229426573658	-0.469636614086187	15	1	0.0175438596491228	57	907	3706	ITPKA
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.625229426573658	-0.469636614086187	15	1	0.0175438596491228	57	907	3706	ITPKA
HUMAN_PWY66-399	gluconeogenesis	0.649177770392066	-0.432048685468211	16	1	0.0175438596491228	57	907	2026	ENO2
META_PWY66-399	gluconeogenesis III	0.649177770392066	-0.432048685468211	16	1	0.0175438596491228	57	907	2026	ENO2
META_PWY66-400	glycolysis VI (metazoan)	0.671620943331466	-0.3980611700311	17	1	0.0175438596491228	57	907	2026	ENO2
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.671620943331466	-0.3980611700311	17	1	0.0175438596491228	57	907	5336	PLCG2
HUMAN_PWY66-400	glycolysis	0.671620943331466	-0.3980611700311	17	1	0.0175438596491228	57	907	2026	ENO2
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.71235819125566	-0.339174416465012	19	1	0.0175438596491228	57	907	10555	AGPAT2
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.71235819125566	-0.339174416465012	19	1	0.0175438596491228	57	907	205	AK4
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.730821685737571	-0.313585780948145	20	1	0.0175438596491228	57	907	129607	CMPK2
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.77950313641711	-0.249098566865575	23	1	0.0175438596491228	57	907	5336	PLCG2
HUMAN_LIPASYN-PWY	phospholipases	0.852357368642896	-0.159749393332062	29	1	0.0175438596491228	57	907	5336	PLCG2
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.913893956178661	-0.0900407359453904	37	1	0.0175438596491228	57	907	205	AK4
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.919535386637183	-0.083886751026637	38	1	0.0175438596491228	57	907	205	AK4
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.919535386637183	-0.083886751026637	38	1	0.0175438596491228	57	907	2026	ENO2
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6076	vitamin D3 biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6620	guanine and guanosine salvage	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY66-397	resolvin D biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PROSYN-PWY	proline biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-5874	heme degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY6666-1	anandamide degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY3O-4106	NAD salvage pathway III	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6620	guanine and guanosine salvage	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-7511	protein ubiquitylation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6118	glycerol-3-phosphate shuttle	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5686	UMP biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY66-14	MAP kinase cascade	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5386	methylglyoxal degradation I	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-4041	gamma-glutamyl cycle	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6482	diphthamide biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PROSYN-PWY	L-proline biosynthesis I	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6181	histamine degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-5177	glutaryl-CoA degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_SERDEG-PWY	L-serine degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_GLUDEG-I-PWY	GABA shunt	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-5670	epoxysqualene biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6145	superpathway of sialic acids and CMP-sialic acids biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-5453	methylglyoxal degradation III	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-7343	UDP-glucose biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
HUMAN_PWY-6608	guanosine nucleotides degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6181	histamine degradation	0.999999999997536	-2.46382168139769e-12	2	0	0	57	907
META_PWY-6823	molybdenum cofactor biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY66-368	ketolysis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-7434	terminal O-glycans residues modification	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-7205	CMP phosphorylation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-2161	folate polyglutamylation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-3781	aerobic respiration I (cytochrome c)	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY66-368	ketolysis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5177	glutaryl-CoA degradation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-6292	cysteine biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-6158	creatine-phosphate biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY66-367	ketogenesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-4921	protein citrullination	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5874	heme degradation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5661	GDP-glucose biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-4984	urea cycle	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-4261	glycerol degradation	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999999199	-8.01362841644677e-13	4	0	0	57	907
HUMAN_PWY66-380	estradiol biosynthesis I	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY-4983	citrulline-nitric oxide cycle	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-6030	serotonin and melatonin biosynthesis	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY-3661-1	glycine betaine degradation	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-6111	mitochondrial L-carnitine shuttle	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY66-367	ketogenesis	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-6074	zymosterol biosynthesis	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-6398	melatonin degradation I	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-4983	L-citrulline-nitric oxide cycle	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_VALDEG-PWY	L-valine degradation I	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-6402	superpathway of melatonin degradation	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY66-201	nicotine degradation IV	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-4061	glutathione-mediated detoxification I	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-4921	protein citrullination	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-4984	urea cycle	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
META_PWY-4081	glutathione redox reactions I	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.999999999999626	-3.73702911114939e-13	5	0	0	57	907
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY66-428	L-threonine degradation V	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY-5972	stearate biosynthesis I (animals and fungi)	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY66-378	androgen biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY-5143	fatty acid activation	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY3DJ-12	ceramide de novo biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_ILEUDEG-PWY	L-isoleucine degradation I	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY-5996	oleate biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY-6074	zymosterol biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY66-378	androgen biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY-7176	UTP and CTP de novo biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY-7455	allopregnanolone biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY-7455	allopregnanolone biosynthesis	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY-4081	glutathione redox reactions I	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
HUMAN_PWY66-428	threonine degradation	0.999999999999744	-2.55827185448474e-13	6	0	0	57	907
META_PWY66-382	mineralocorticoid biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-5331	taurine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-6609	adenine and adenosine salvage III	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-5331	taurine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_GLYCLEAV-PWY	glycine cleavage	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY66-392	lipoxin biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-6875	retinoate biosynthesis II	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-6430	thymine degradation	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY66-381	glucocorticoid biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY66-301	catecholamine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-6100	L-carnitine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY0-1296	purine ribonucleosides degradation	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-3982	uracil degradation	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY0-1182	trehalose degradation	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-6100	L-carnitine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-7177	UTP and CTP dephosphorylation II	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-7527	L-methionine salvage cycle III	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-6609	adenine and adenosine salvage III	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-3982	uracil degradation I (reductive)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_GLUDEG-I-PWY	GABA shunt	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-5453	methylglyoxal degradation III	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY66-221	nicotine degradation V	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY66-392	lipoxin biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-7283	wybutosine biosynthesis	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-7185	UTP and CTP dephosphorylation I	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY66-422	D-galactose degradation V (Leloir pathway)	0.999999999999825	-1.75164082457518e-13	3	0	0	57	907
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6133	(S)-reticuline biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY66-421	homocarnosine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_P121-PWY	adenine and adenosine salvage I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5686	UMP biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5148	acyl-CoA hydrolysis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6399	melatonin degradation II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5905	hypusine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5966	fatty acid biosynthesis initiation II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-46	putrescine biosynthesis III	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6898	thiamin salvage III	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6132	lanosterol biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY0-522	lipoate salvage	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6377	alpha-tocopherol degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5326	sulfite oxidation IV	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_BGALACT-PWY	lactose degradation III	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-40	putrescine biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6012-1	acyl carrier protein metabolism II (mammalian)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6938	NADH repair	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PROUT-PWY	proline degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7299	progesterone biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5326	sulfite oxidation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY0-1305	glutamate dependent acid resistance	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_GLNSYN-PWY	L-glutamine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-4101	sorbitol degradation I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_SERDEG-PWY	L-serine degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-40	putrescine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7306	estradiol biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-7299	progesterone biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6619	adenine and adenosine salvage VI	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY66-421	homocarnosine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5766	L-glutamate degradation X	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6173	histamine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY66-241	bupropion degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY66-366	flavin biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY66-420	carnosine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7344	UDP-D-galactose biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_ALANINE-DEG3-PWY	L-alanine degradation III	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6938	NADH repair	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6132	lanosterol biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY6666-1	anandamide degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY66-420	carnosine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-46	putrescine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_MANNCAT-PWY	D-mannose degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6535	4-aminobutyrate degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6173	histamine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6481	L-dopachrome biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY0-1313	acetate conversion to acetyl-CoA	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY0-1021	L-alanine biosynthesis III	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6134	L-tyrosine biosynthesis IV	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation II (mammalian)	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_GLNSYN-PWY	glutamine biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-5269	cardiolipin biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6481	L-dopachrome biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6241	thyroid hormone biosynthesis	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6535	4-aminobutanoate degradation I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6619	adenine and adenosine salvage II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY-6334	L-dopa degradation	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_PWY66-11	BMP Signalling Pathway	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
META_PWY-6133	(S)-reticuline biosynthesis II	1.00000000000023	2.28567165194704e-13	1	0	0	57	907
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.00000000000092	9.15530278663474e-13	8	0	0	57	907
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.00000000000092	9.15530278663474e-13	8	0	0	57	907
HUMAN_PWY-7434	terminal O-glycans residues modification	1.00000000000092	9.15530278663474e-13	8	0	0	57	907
HUMAN_PWY-2201	folate transformations I	1.00000000000092	9.15530278663474e-13	8	0	0	57	907
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	1.00000000000092	9.15530278663474e-13	8	0	0	57	907
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	1.00000000000092	9.15530278663474e-13	8	0	0	57	907
META_PWY-5920	superpathway of heme biosynthesis from glycine	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY66-374	C20 prostanoid biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY-5994	palmitate biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
META_PWY66-374	C20 prostanoid biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
META_PWY-5130	2-oxobutanoate degradation I	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY-5920	heme biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY66-373	sucrose degradation	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY-5067	glycogen biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
META_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
META_DETOX1-PWY-1	reactive oxygen species degradation	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY-5130	2-oxobutanoate degradation	1.00000000000098	9.79774907598199e-13	7	0	0	57	907
HUMAN_PWY-6353	purine nucleotides degradation	1.00000000000197	1.97009143823257e-12	9	0	0	57	907
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000197	1.97009143823257e-12	9	0	0	57	907
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	1.00000000000197	1.97009143823257e-12	9	0	0	57	907
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	1.00000000000197	1.97009143823257e-12	9	0	0	57	907
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	1.00000000000197	1.97009143823257e-12	9	0	0	57	907
HUMAN_PWY-7527	methionine salvage cycle III	1.00000000000197	1.97009143823257e-12	9	0	0	57	907
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	1.00000000000197	1.97009143823257e-12	9	0	0	57	907
META_PWY66-341	cholesterol biosynthesis I	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
HUMAN_PWY-6309	L-kynurenine degradation	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
HUMAN_PWY-5972	stearate biosynthesis	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
HUMAN_LIPAS-PWY	triacylglycerol degradation	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	1.00000000000304	3.0401874832349e-12	11	0	0	57	907
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	1.00000000000326	3.26391202018786e-12	10	0	0	57	907
META_PWY-922	mevalonate pathway I	1.00000000000326	3.26391202018786e-12	10	0	0	57	907
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000326	3.26391202018786e-12	10	0	0	57	907
HUMAN_PWY-922	mevalonate pathway	1.00000000000326	3.26391202018786e-12	10	0	0	57	907
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	1.00000000000326	3.26391202018786e-12	10	0	0	57	907
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	1.00000000000326	3.26391202018786e-12	10	0	0	57	907
HUMAN_VALDEG-PWY	valine degradation	1.00000000000404	4.03972137410701e-12	12	0	0	57	907
META_PWY-6857	retinol biosynthesis	1.00000000000404	4.03972137410701e-12	12	0	0	57	907
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000000404	4.03972137410701e-12	12	0	0	57	907
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000000404	4.03972137410701e-12	12	0	0	57	907
HUMAN_ILEUDEG-PWY	isoleucine degradation	1.00000000000404	4.03972137410701e-12	12	0	0	57	907
HUMAN_PWY-6000	gamma-linolenate biosynthesis	1.00000000000404	4.03972137410701e-12	12	0	0	57	907
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000000506	5.05993822884437e-12	13	0	0	57	907
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	1.00000000000506	5.05993822884437e-12	13	0	0	57	907
HUMAN_PWY66-341	cholesterol biosynthesis I	1.00000000000506	5.05993822884437e-12	13	0	0	57	907
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	1.00000000000506	5.05993822884437e-12	13	0	0	57	907
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	1.00000000000506	5.05993822884437e-12	13	0	0	57	907
META_PWY66-409	superpathway of purine nucleotide salvage	1.00000000000506	5.05993822884437e-12	13	0	0	57	907
META_PWY-6861	the visual cycle I (vertebrates)	1.00000000000506	5.05993822884437e-12	13	0	0	57	907
META_FAO-PWY	fatty acid beta-oxidation I	1.00000000000535	5.35486095974001e-12	14	0	0	57	907
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000000535	5.35486095974001e-12	14	0	0	57	907
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	1.00000000000535	5.35486095974001e-12	14	0	0	57	907
HUMAN_FAO-PWY	fatty acid beta-oxidation	1.00000000000535	5.35486095974001e-12	14	0	0	57	907
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000535	5.35486095974001e-12	14	0	0	57	907
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000535	5.35486095974001e-12	14	0	0	57	907
META_PWY66-398	TCA cycle III (animals)	1.00000000000706	7.06252124681871e-12	16	0	0	57	907
HUMAN_PWY66-398	TCA cycle	1.00000000000706	7.06252124681871e-12	16	0	0	57	907
HUMAN_PWY-6861	the visual cycle I (vertebrates)	1.00000000000719	7.19341066130731e-12	15	0	0	57	907
HUMAN_PWY-6857	retinol biosynthesis	1.0000000000084	8.3997817990302e-12	17	0	0	57	907
META_PWY-6368	3-phosphoinositide degradation	1.00000000000996	9.9559399045028e-12	19	0	0	57	907
HUMAN_PWY-6368	3-phosphoinositide degradation	1.00000000001068	1.06836785354518e-11	20	0	0	57	907
META_PWY66-5	superpathway of cholesterol biosynthesis	1.00000000001101	1.10053944009099e-11	23	0	0	57	907
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	1.0000000000127	1.27043568291224e-11	25	0	0	57	907
